Table 1.
Variables | RT | VAS | HMPMT | KWT |
---|---|---|---|---|
Qualitative variables | ||||
Patient referral (primary care, other specialists, or own free will) | 0.786 | 0.661 | 0.197 | 0.112 |
Level of studies (basic, secondary, or university) | 0.967 | 0.171 | 0.053 | 0.048 |
Quit-smoking reasons | ||||
Health/prevention | 0.973 | 0.422 | 0.114 | 0.068 |
Health/decrease in symptoms | 0.939 | 0.388 | 0.020 | 0.670 |
Stop being dependent | 0.973 | 0.370 | 0.115 | 0.060 |
Saving money | 0.973 | 0.398 | 0.136 | 0.079 |
Quality of life | 0.973 | 0.419 | 0.182 | 0.063 |
Do not harm my children/partner | 0.973 | 0.394 | 0.123 | 0.843 |
Be a good example | 0.853 | 0.414 | 0.113 | 0.090 |
Number of reasons for quit smoking | 0.820 | 0.431 | 0.123 | 0.096 |
Smoking situation | ||||
Father smokes/smoked | 0.951 | 0.476 | 0.340 | 0.035 |
Mother smokes/smoked | 0.887 | 0.491 | 0.170 | 0.064 |
Older brother smokes/smoked | 0.755 | 0.213 | 0.071 | 0.788 |
Other brothers smoke | 0.894 | 0.360 | 0.062 | 0.020 |
Friends smoke | 0.906 | 0.408 | 0.175 | 0.056 |
Co-workers smoke | 0.976 | 0.640 | 0.243 | 0.193 |
Illness | ||||
COPD | 0.986 | 0.362 | 0.040 | 0.401 |
Asthma | 0.888 | 0.432 | 0.119 | 0.066 |
Diabetes mellitus | 0.970 | 0.378 | 0.110 | 0.090 |
Arterial hypertension | 0.888 | 0.568 | 0.127 | 0.080 |
Ischemic heart disease | 0.888 | 0.745 | 0.116 | 0.129 |
Lung cancer | 0.978 | 0.442 | 0.113 | 0.084 |
Bladder cancer, cerebral strokeb | - | - | - | - |
Depression | 0.943 | 0.460 | 0.119 | 0.056 |
Anxiety | 0.888 | 0.297 | 0.093 | 0.039 |
Dependence tests | ||||
Fagerström test | 0.730 | 0.484 | 0.136 | 0.071 |
Heaviness of Smoking Index test | 0.730 | 0.471 | 0.117 | 0.064 |
Type of treatmentc | ||||
Pharmacological/psychological treatment typed | 0.861 | 0.420 | 0.953 | 0.309 |
Treatment alone vs combinede | 0.917 | 0.270 | 0.191 | 0.358 |
Varenicline alone or combined vs other treatments vs without treatment | 0.917 | 0.470 | 0.121 | 0.064 |
Types of NRT treatmentsf | ||||
Patches | 0.723 | 0.414 | 0.186 | 0.068 |
Gums | 0.723 | 0.461 | 0.145 | 0.087 |
Tablets | 0.723 | 0.473 | 0.169 | 0.790 |
Oral spray | 0.723 | 0.581 | 0.075 | 0.098 |
Patches + gums | 0.723 | 0.477 | 0.135 | 0.049 |
Patches + tablets | 0.723 | 0.409 | 0.237 | 0.504 |
Patches + oral spray | 0.723 | 0.456 | 0.110 | 0.526 |
Other combinationsg | - | - | - | - |
Number of NRT therapies | 0.723 | 0.533 | 0.196 | 0.076 |
Nicotine dependence treatments | ||||
Varenicline alone | 0.723 | 0.554 | 0.206 | 0.077 |
Bupropion alone | 0.693 | 0.498 | 0.250 | 0.072 |
NRT alone | 0.805 | 0.623 | 0.194 | 0.396 |
Quantitative variablesh | ||||
Demographic | ||||
Age (years) | 0.730 | 0.531 | 0.150 | 0.581 |
Sex | 0.730 | 0.534 | 0.187 | 0.610 |
Age and sex | 0.730 | 0.506 | 0.147 | 0.127 |
Age of initiation (years) | 0.956 | 0.019 | 0.129 | 0.053 |
Smoking status | ||||
Cigarettes/day | 0.917 | 0.471 | 0.117 | 0.065 |
Number of years smoking | 0.956 | 0.154 | 0.129 | 0.053 |
Cumulative consumption (pack-years) | 0.956 | 0.451 | 0.125 | 0.056 |
Number of previous quit attempts | 0.917 | 0.728 | 0.006 | 0.071 |
Number of previous quit attempts (past/year) | 0.917 | 0.517 | 0.118 | 0.068 |
Physical/psychological characteristics | ||||
Weight | 0.524 | 0.750 | 0.306 | 0.433 |
Height | 0.709 | 0.721 | 0.220 | 0.010 |
BMI | 0.709 | 0.760 | 0.275 | 0.073 |
Carbon monoxide (ppm) | 0.598 | 0.061 | 0.012 | <0.001 |
VAS | 0.917 | 0.470 | 0.119 | 0.066 |
HMPMT | 0.917 | 0.721 | 0.155 | 0.585 |
KWT | 0.917 | 0.875 | 0.192 | 0.093 |
RT: Richmond Test for quitting smoking. VAS: visual analogue scale. HMPMT: Henry Mondor Paris Motivation Test. KWT: Khimji-Watts Test. BMI: body mass index (kg/m2). NRT: nicotine replacement therapy. COPD: chronic obstructive pulmonary disease.
The models include the mentioned variables and all their possible interactions.
These variables were not analyzed as only one subject had this antecedent.
In the treatment models, the variable Type of treatment used so far, namely, Varenicline alone or Combined vs Other treatments vs No treatment that contains the categories No treatment, Other treatments, and Varenicline-containing treatments, is replaced by the specific treatment variable mentioned.
Categorized as: No treatment (Reference category), Only pharmacological treatment, Only psychological treatment, and Pharmacological and psychological treatment.
Categorized as: No treatment (Reference category), Varenicline, Bupropion or NRT alone, and Combined treatment (Varenicline + NRT, Varenicline + Bupropion, or Bupropion + NRT).
Nicotine replacement therapy.
Other combinations of nicotine replacement therapy were not studied due to the small number of effective treatments.
The models with the variables: Age only, Sex only, and Age and Sex, do not include the variable Treatment. Starting with the variable Age of initiation, the models include the variables mentioned in the title of the table.